AJGP
HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a Colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nishioka, N.
Right arrow Articles by Arnold, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nishioka, N.
Right arrow Articles by Arnold, S. E.
Am J Geriatr Psychiatry 12:167-175, April 2004
© 2004 American Association for Geriatric Psychiatry


Regular Article

Evidence for Oxidative DNA Damage in the Hippocampus of Elderly Patients With Chronic Schizophrenia

Naoya Nishioka, M.D., Ph.D., and Steven E. Arnold, M.D.

Received January 2, 2004; revised January 6 2004; accepted January 12, 2004. From the Cellular and Molecular Neuropathology Program, Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia, PA. Send correspondence to Steven E. Arnold, M.D., 547 Clinical Research Bldg., 415 Curie Blvd., Philadelphia, PA 19104. e-mail: sarnold{at}mail.med.upenn.edu
© 2004 American Association for Geriatric Psychiatry

Objective: The authors investigated the idea that some patients with schizophrenia exhibit a chronic, deteriorating course without showing frank neurodegeneration at postmortem examination. Oxidative damage is one form of cellular injury that may cause cellular dysfunction without necessarily leading to neuron death. Methods: Authors obtained postmortem hippocampi from 13 elderly non-psychiatric comparison cases and 10 patients with "poor-outcome" schizophrenia. The groups were compared for the presence of neuronal 8-hydroxy, 2' deoxyguanosine (8-OHdG), a robust marker of oxidized DNA, and neuronal Ki-67, a marker of cell-cycle activation, as well as neurofibrillary tangles, amyloid-beta senile plaques, and astrocytosis. Results: The mean proportion of neurons exhibiting 8-OHdG immunoreactivity was 10 times higher in schizophrenia than in comparison cases. Ki-67 was similarly elevated and was correlated with 8-OHdG in the schizophrenia group. There were no significant between-group differences for densities of neurofibrillary tangles, amyloid-beta plaques, or astrocytes. Conclusions: Our data provide evidence for oxidative DNA damage and coordinated cell-cycle activation in elderly "poor-outcome" schizophrenia. These findings could have important implications for cellular metabolism, gene expression, and membrane functioning in schizophrenia.

Key Words: Neurophysiology • Genetics • Medical Comorbidity • Schizophrenia




This article has been cited by other articles:


Home page
AJGPHome page
S. E. Arnold
Bedside to Bench and Back Again: Translational Neuroscience Research and Geriatric Psychiatry
Am J Geriatr Psychiatry, April 1, 2004; 12(2): 122 - 125.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
Copyright © 2004 American Association for Geriatric Psychiatry